March 29, 2010 Free Edition of the Monday Morning Review

THIS WEEK'S STOCK MARKET TREND SIGNALS   *************************************************************************** (The signals shown below are the "regular" MACD signals, NOT the Advanced MACD signals, which are available separately for only $4.95 a month.  See our website for details).   Shown below are the current "Weekly" signals for the Dow Jones Industrials, S&P 500, and NASDAQ using the "regular" MACD (as is available for free on many investment websites).  These can change quickly, but can also go weeks or months between changes, so be sure to check each week's email.  The Longer-Term "Monthly" signals (rarely change) are shown below.  Then, at the bottom we provide our big trends for interest rates.   Dow Jones Signal       S&P 500 Signal            NASDAQ Signal        LONGER-TERM (L-T) STOCK MARKET TREND SIGNALS (The signals shown below are the "regular" MACD signals, NOT the Advanced MACD signals, which are available separately for only $4.95 a month). These longer-term signals are based on 'monthly' intervals for the "regular" MACD, meaning that signals can only change at the beginning of the month.  As such, these signals can go for months or years between changes - BUT when they do change it pays to take heed, since it signals a potentially VERY IMPORTANT change in trend or direction for the market as a whole.  Subscribers that don't change their investments very often will usually follow these signals since they don't change very often.   L-T Dow Jones Signal   L-T S&P 500 Signal       L-T NASDAQ Signal      INTEREST RATE OUTLOOK   These interest rate outlooks are based on the price and yield trends for U.S. Treasury bonds of various maturities.  This kind of information is helpful for those investing in certificates of deposit, applying for a loan, and other reasons where the interest rate outlook is critical.  While rates could move counter to the signals shown below from time to time, we show the LARGE trends for these rates, based on the monthly interval MACD.   Short-term (3-6 Months)   Medium-term (2yrs-5yrs) Long-term (10yrs-30yrs)         COMMENTARY:   Bumpy Ride, Heathcare Drama, But Green Arrows Say Go  (BE CAREFUL THOUGH!)   This week's newsletter will be short and simple -- not because there isn't a lot going on, but there is so much going on, we are working overtime trying digest it all (especially the healthcare bill!)  Instead we will give a quick update and broad overview of the super-critical items at this time.  And, before we forget, please consider subscribing to our $4.95 newsletter and asking others to as well.  We anticipate some rather hair-raising market action, and we can't accomplish our mission to keep people informed without more revenue.  We don't ask for donations, and the $4.95 is a small amount for the information we provide.  But, without paid subscriptions, we can no longer operate.  Your support keeps us going.  Now, let's get into what's happening at this time.   Last week was huge, and on the day the new healthcare bill was passed, the Drudge Report's headline was, "The Day That Will Live in Infirmary".  We agree, but let's take a look at the MACD's first.   We may not like the investment environment today, but the regular weekly and regular monthly MACD's for each of the major markets (Dow Jones Industrials, S&P 500, and NASDAQ) say it's time to be in stocks...yes, time to buy stocks!  But, read on (since you know it's not quite that simple!)  As shocking as this "uptrend" sounds given what's happened as recently as last week (signing into law the healthcare bill), all three MACD's are clear: the overall stock market trend is up.  Be warned though, that the legislation coming out of Washington D.C., busted state, county and municipal governments, Greece and sovereign debt, and many other items could upset the apple cart, quickly changing this recent uptrend.  This means that it may be best to treat this uptrend as being "cautiously optimistic".  In fact, there are some signs this rally is in trouble (see our Adva nced MACD analysis for details).  Regardless of all the drastic changes and worrying developments, the MACD's are reflecting "green arrows" meaning it's time to be in stocks, or at least consider adding to them.  Again, we are not investment advisers, meaning stocks are not appropriate for everyone, and the amount one invests in any particular asset depends on their tolerance for risk, and investment goals and objectives.   Now, a word or two about the recently passed healthcare bill.  We aren't going to comment on it much this week since it's so massive, and we have to read it for ourselves.  However, based on the analysis we've been reading so far, this new law isn't only about healthcare!  It could be one of the most awful, draconian pieces of legislation to come out of our federal government, and unconstitutional.  The legality of the law we have to leave to the States Attorney's General and Supreme Court, but as for what's in the law, we will read that for ourselves (even though we hear that many Congressman didn't even read it).  Naturally, our paid subscribers to the Advanced MACD newsletter will get the more detailed analysis, what specifically could affect Americans (that's only fair).  However, we will give our overall assessment for our free newsletter subscribers in the weeks ahead.   Watch the markets closely now, since things could get bumpy soon (this week?).  In fact, we have a few warnings about next week that will be in the Advanced MACD newsletter you may want to know about.  And, once again, please pass the word about our newsletter if you like it, consider subscribing, calling in to talk shows and letting other know about it, and letting anyone else know you think could use it.  We truly appreciate each one of our subscribers, and it makes us feel good knowing we are helping people.   Take care, and all the best for your health and investment portfolio.      J.E. Rapp, Editor-in-Charge       LEGAL STUFF: Copyright © 2005-2010 MMR Publishing, LLC    All Rights Reserved   The content on this newsletter is provided without any warranty, express or implied. All opinions expressed on this website and newsletter are those of the author(s) and may contain errors or omissions. NO MATERIAL HERE CONSTITUTES "INVESTMENT ADVICE" NOR IS IT A RECOMMENDATION TO BUY OR SELL ANY FINANCIAL INSTRUMENT, INCLUDING BUT NOT LIMITED TO STOCKS, OPTIONS, BONDS OR FUTURES. The author may or may not have a position in any company or security mentioned herein. Actions you undertake as a consequence of any analysis, opinion or advertisement on this site are your sole responsibility.  Please refer to our website for a full description of our Terms, Conditions and Disclaimers, relative to our website and any of our publications and communications.  Monday Morning Review content may be reproduced or excerpted online provided full attribution is given and the original article source is linked to.  Please contact Editor-in-Charge, J.E. Rapp, for reprint permission in other media.    All contents of this email publication are subject to Copyright law and other Conditions of Use, Disclaimers, and other user information.  No specific investment advise is given, intended, or implied. For full details regarding our Conditions of Use, Disclaimers, and other information, see our website at: www.MondayMorningReview.com